Interim PET in lymphoma
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Interim PET in lymphoma |
| Type de publication | Journal Article |
| Year of Publication | 2014 |
| Auteurs | Casasnovas O. |
| Journal | MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE |
| Volume | 38 |
| Pagination | 184–187 |
| Date Published | MAY |
| Type of Article | Article |
| ISSN | 0928-1258 |
| Mots-clés | Interim PET, lymphoma, prognosis, SUV |
| Résumé | 18-FDG-PET (PET) performed after 2 to 4 cycles of chemotherapy, allows predicting the outcome of diffuse large B cell and Hodgkin lymphoma patients. Interim PET is currently assessed in many clinical trials to guide the treatment strategy. While this approach remains to be validated, the risk-adapted strategy based on interim PET might completely modify the management of DLBCL and HL patients in routine practice during the next years. (C) 2014 Published by Elsevier Masson SAS. |
| DOI | 10.1016/j.mednuc.2014.03.007 |